(Q42849047)

8 November 2017

title

Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients (English)

1 reference

8 November 2017

0 references

1 reference

1 reference

Lu-lu Chen

1

1 reference

8 November 2017

Yun-fei Liao

2

1 reference

8 November 2017

Tian-shu Zeng

3

1 reference

8 November 2017

Fan Yu

4

1 reference

8 November 2017

Hui-qing Li

5

1 reference

8 November 2017

Yong Feng

6

1 reference

8 November 2017

language of work or name

1 reference

23 October 2010

1 reference

full work available at URL

8 November 2017

http://link.springer.com/content/pdf/10.1007/s12020-010-9383-8.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S12020-010-9383-8

http://link.springer.com/article/10.1007/s12020-010-9383-8/fulltext.html

9 August 2024

1 reference

https://api.crossref.org/works/10.1007/S12020-010-9383-8

http://link.springer.com/content/pdf/10.1007/s12020-010-9383-8

9 August 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S12020-010-9383-8

9 August 2024

1 reference

8 November 2017

volume

38

1 reference

8 November 2017

issue

2

1 reference

8 November 2017

page(s)

266-275

1 reference

Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives.

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Significance of endothelial progenitor cells in subjects with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Oral antidiabetic agents as cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Standards of medical care in diabetes--2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Inseparably tied: functional and antioxidative capacity of endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Circulating endothelial progenitor cells and cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9383-8

Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures

21 January 2018

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment

1 reference

12 December 2020

Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy

1 reference

12 December 2020

Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes

1 reference

12 December 2020

The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome

1 reference

12 December 2020

Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet

1 reference

12 December 2020

A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin

1 reference

12 December 2020

Vascular benefits of gliclazide beyond glycemic control.

1 reference

12 December 2020

Identifiers

DOI

1 reference

Dimensions Publication ID

8 November 2017

1019050745

0 references

1 reference